<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343510</url>
  </required_header>
  <id_info>
    <org_study_id>lab7682</org_study_id>
    <nct_id>NCT02343510</nct_id>
  </id_info>
  <brief_title>Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study</brief_title>
  <official_title>Detection of Chlamydia DNA by Polymerase Chain Reaction ( PCR ) in Tumours Tissue of Primary Tubal and Ovarian Cancers : a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PCR for chlamydia DNA is done in paraffin blocks of cases of primary tubal cancer and is
      compared to cases of high grade serous ovarian cancer and normal tubes .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators shall review the early cancer detection unite pathology records for the
      past 10 years , for cases diagnosed with primary Fallopian tube cancers , cases of high and
      low grade serous ovarian cancer and cases underwent hysterectomy and salpingectomy for non
      oncological reasons. Paraffin blocks for suitable selected patients will be examined
      histologically to confirm the primary diagnosis . Chlamydia DNA in these paraffin blocks of
      the Fallopian tubes and ovarian tissues will be examined using PCR techniques . The possible
      correlation between the presence of Chlamydia DNA and the ovarian serous tumours and primary
      tubal cancer will be analyzed statistically .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of chlamydia DNA in tubal and ovarian tissues</measure>
    <time_frame>Up to 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of concomitant tubal cancer with high grade serous ovarian cancer</measure>
    <time_frame>Up to 8 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">70</enrollment>
  <condition>Malignant Neoplasm of Fallopian Tube</condition>
  <arm_group>
    <arm_group_label>primary tubal cancer group</arm_group_label>
    <description>Paraffin blocks of cases of primary tubal cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high grade serous ovarian cancer group</arm_group_label>
    <description>Paraffin blocks of cases of high grade serous ovarian cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Grade Serous Ovarian Cancer</arm_group_label>
    <description>Paraffin blocks of cases of low grade serous ovarian cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal tubes group</arm_group_label>
    <description>Paraffin blocks of tubes of hysterectomies due to non-oncologic causes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PCR for chlamydia DNA in primary tubal cancer</intervention_name>
    <description>PCR for presence of chlamydia DNA in paraffin blocks retrieved for tubal and ovarian tissues in all groups</description>
    <arm_group_label>primary tubal cancer group</arm_group_label>
    <arm_group_label>high grade serous ovarian cancer group</arm_group_label>
    <arm_group_label>Low Grade Serous Ovarian Cancer</arm_group_label>
    <arm_group_label>normal tubes group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Archival Paraffin blocks for cases of primary tubal cancers , high grade serous ovarian
      cancers , low grade serous ovarian cancers and normal Fallopian tubes removed during
      Hysterectomy operations for benign Gynecological indications
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pathology blocks of patients with primary tubal cancer and with high grade serous ovarian
        cancer and normal tubes.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any patient with primary tubal cancer and high grade serous cancer and normal tubes.

        Exclusion Criteria:

          -  clinical pelvic inflammatory disease

          -  salpingectomy for ectopic
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2015</study_first_submitted>
  <study_first_submitted_qc>January 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>July 16, 2017</last_update_submitted>
  <last_update_submitted_qc>July 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>dr mohamed laban</investigator_full_name>
    <investigator_title>professor mohammed laban</investigator_title>
  </responsible_party>
  <keyword>Fallopian tubal cancer, high grade serous , ovarian cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Fallopian Tube Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

